iCamuno Biotherapeutics Pty Ltd

iCamuno Biotherapeutics is a pioneering biotechnology company specializing in Induced Pluripotent Stem (iPS) Cell therapies for immunology and regenerative medicine. Leveraging proprietary cell reprogramming technologies, AI-powered cell differentiation platforms, precise gene editing capabilities, and state-of-the-art GMP cell manufacturing suites, iCamuno delivers innovative therapeutic solutions.
Our advanced target identification and disease modeling platform facilitates precise understanding of diseases, guiding effective treatment strategies. Committed to scientific excellence, iCamuno integrates multidisciplinary expertise to accelerate the development of groundbreaking stem cell-based therapies, addressing critical clinical challenges in immunology and regenerative medicine.